Michela Tindera, Forbes Staff

Author's details

Name: Michela Tindera, Forbes Staff
Date registered: November 4, 2016
URL: http://www.forbes.com/healthcare/

Latest posts

  1. Single Cell Sequencing Startup Mission Bio Raises $30 Million — December 13, 2018
  2. Fentanyl Billionaire No More: John Kapoor’s Net Worth Drops Below $1 Billion — December 7, 2018
  3. Healthcare Startups Raised $2.2 Billion In November — December 3, 2018
  4. Novartis CEO Vas Narasimhan On The Price Of Gene Therapies: ‘It’s A Challenge We Have To Solve’ — November 29, 2018
  5. Why Billionaire Venture Capitalist John Doerr Thinks Healthcare Needs An ‘App Store’ — November 28, 2018

Author's posts listings

Single Cell Sequencing Startup Mission Bio Raises $30 Million

Mission Bio has raised $30 million Series B from investors such as Mayfield, Agilent Technologies and LabCorp.

Fentanyl Billionaire No More: John Kapoor’s Net Worth Drops Below $1 Billion

The founder of embattled fentanyl manufacturer Insys Therapeutics is no longer a billionaire.

Healthcare Startups Raised $2.2 Billion In November

Venture capital fundraising among healthcare startups was down 25% to $2.18 billion in November compared the same month one year ago, according to an analysis conducted for Forbes by Pitchbook.

Novartis CEO Vas Narasimhan On The Price Of Gene Therapies: ‘It’s A Challenge We Have To Solve’

In May Novartis announced that it had acquired the gene therapy pioneer AveXis in a $8.7 billion deal, but according to the the Swiss drug giant CEO Vas Narasimhan, he wishes he could have bought the company much earlier.

Why Billionaire Venture Capitalist John Doerr Thinks Healthcare Needs An ‘App Store’

What does the healthcare industry really need? An app store, says legendary Kleiner Perkins venture capitalist John Doerr.

It’s Lights Out For Novartis And Verily’s Glucose Monitoring ‘Smart Lens’ Project

Alphabet’s Verily and Novartis eye-care subsidiary Alcon are pulling the plug on the glucose monitoring “smart lens” device the two companies had been attempting to build since 2014, according to a post by Verily chief technical officer Brian Otis on t…

Hemophilia, The Musical? It’s Funded By Biotech BioMarin

Rare disease drug company BioMarin put on a show called ‘Hemophilia: The Musical’ performed by teenagers affected by blood disorders.

A Spine-Surgery Robot Turned This Entrepreneur Into A Billionaire. But How Well Does His Robot Work?

David C. Paul is riding high on a million-dollar robot designed to make spinal surgeons more accurate. But how effective is it?

These 30 Under 30 Founders Want Your Genome

A startup cofounded by Harvard genomics pioneer George Church and two Forbes 30 Under 30 members is now seeking people who want to have their genome sequenced.

A 29-Year-Old CEO Who’s Shaking Up Diagnostics & Other Stories From The 2019 Healthcare 30 Under 30

Meet the newest crop of 30 Under 30 researchers and entrepreneurs working in healthcare.

Older posts «

Explore the Archive